US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Definium Therapeutics

37.85

+1.032.80%

Pre-market: 38.280.4300+1.14%07:34 EDT

Volume:2.07M

Turnover:78.79M

Market Cap:5.09B

PE:-10.87

High:38.92

Open:36.99

Low:36.70

Close:36.82

52wk High:49.70

52wk Low:8.77

Shares:134.37M

Float Shares:129.77M

Volume Ratio:0.64

T/O Rate:1.60%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.4823

EPS(LYR):-2.0600

ROE:-64.09%

ROA:-20.64%

PB:5.54

PE(LYR):-18.37

Loading ...

Overview Company News Filings

Definium Therapeutics: DT120 Odt 100 Mcg Generally Well Tolerated with Consistent Safety Profile; no New Safety Signals

THOMSON REUTERS

Definium Therapeutics: DT120 Pre-Nda Meeting Scheduled for Q4; Nda Filing Expected H1 2027

THOMSON REUTERS

Definium Therapeutics: Phase 3 Panorama Study of DT120 Odt Met Primary & Key Secondary Endpoints in Generalized Anxiety Disorder

THOMSON REUTERS

Definium's LSD-Based Drug Lowers Anxiety in Second Successful Late-Stage Study

Definium Therapeutics: DT120 Odt 100 Mcg Showed Placebo-Adjusted Hamilton Anxiety Rating Scale Reduction of 5.1 Points at Week 12

THOMSON REUTERS

NASDAQ Trade Halt Halt News Pending at 06:55 Am

U.S. Research Roundup-ACV Auctions, Crown Castle, Lennox International

Definium Therapeutics Issues Inducement Stock Options for 56,650 Shares to New Hires

Definium Therapeutics to Present Phase 3 Panorama Topline Data for DT120 in Generalized Anxiety Disorder Sept. 14

Definium Therapeutics to Discuss Topline Results from Phase 3 Panorama Study in Generalized Anxiety Disorder on September 14, 2026

THOMSON REUTERS

Definium Therapeutics' Upcoming Phase 3 Data on DT120 to De-Risk Program, Back FDA Approval, RBC Says

MT Newswires Live

Definium Therapeutics Price Target Maintained with a $66.00/Share by RBC Capital

Definium Therapeutics announce six poster presentations at Psych Congress

Definium Therapeutics to Present Phase 3 Topline Data for DT120 in MDD, GAD at Psych Congress 2026

Analyst Reiterates Buy on Definium Therapeutics, Maintains $75 Price Target Following De-Risking of DT120 ODT in MDD and GAD

U.S. Stocks on the MOVE-Best Buy, Peloton, Apple

Definium Rises on FDA's 'breakthrough' Tag for Depression Drug

Definium Therapeutics Gains FDA Breakthrough for Depression Drug

Definium Therapeutics receives Breakthrough Therapy designation for DT120 ODT

Definium Therapeutics’ DT120 LSD Tablet Wins FDA Breakthrough Tag in Major Depressive Disorder After Phase 3 Study

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/DFTX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DFTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","market":"US","secType":"STK","nameCN":"Definium Therapeutics","latestPrice":37.85,"timestamp":1789588800000,"preClose":36.82,"halted":0,"volume":2069955,"hourTrading":{"tag":"盘前","latestPrice":38.28,"preClose":37.85,"latestTime":"07:34 EDT","volume":342,"amount":13033.283472,"timestamp":1789644892338,"change":0.43,"changeRate":0.011361,"amplitude":0.016909},"delay":0,"changeRate":0.02797392721347097,"floatShares":129766311,"shares":134366950,"eps":-3.482311,"marketStatus":"Pre-Mkt","change":1.03,"latestTime":"09-17 07:36:09 EDT","open":36.99,"high":38.92,"low":36.7,"amount":78792557.631075,"amplitude":0.060293,"askPrice":38.61,"askSize":16,"bidPrice":38.26,"bidSize":15,"shortable":3,"etf":0,"ttmEps":-3.482311,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789651800000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":37.85,"preHourTrading":{"tag":"盘前","latestPrice":38.28,"preClose":37.85,"latestTime":"07:34 EDT","volume":342,"amount":13033.283472,"timestamp":1789644892338,"change":0.43,"changeRate":0.011361,"amplitude":0.016909},"postHourTrading":{"tag":"盘后","latestPrice":37.96,"preClose":37.85,"latestTime":"19:59 EDT","volume":354011,"amount":13399804.4435,"timestamp":1789603150319,"change":0.11,"changeRate":0.002906,"amplitude":0.024835},"volumeRatio":0.6365906163662345,"impliedVol":0.7863,"impliedVolPercentile":0.1317},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","floatShares":129766311,"roa":"-20.64%","roe":"-64.09%","lyrEps":-2.059999,"volumeRatio":0.6365906163662345,"shares":134366950,"dividePrice":0,"high":38.92,"amplitude":0.060293,"preClose":36.82,"low":36.7,"week52Low":8.7732,"pbRate":"5.54","week52High":49.7,"institutionHeld":0,"latestPrice":37.85,"committee":-0.032258,"eps":-3.482311,"divideRate":0,"volume":2069955,"delay":0,"ttmEps":-3.482311,"open":36.99,"prevYearClose":13.39,"prevWeekClose":38.89,"prevMonthClose":39.72,"prevQuarterClose":47.04,"fiveDayClose":37.99,"twentyDayClose":46.18,"sixtyDayClose":36.67},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DFTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"DFTX","fiscalQuarterEnding":"2026/06","expectedEps":-0.55,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-1.44},{"market":"US","date":"2026-05-07","symbol":"DFTX","fiscalQuarterEnding":"2026/03","expectedEps":-0.47,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.71},{"market":"US","date":"2026-02-26","symbol":"DFTX","fiscalQuarterEnding":"2025/12","expectedEps":-0.45,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"post","actualEps":-0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DFTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DFTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3889,"buy":0.6111,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6111,"analysts":18,"updateTime":1787025600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DFTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DFTX","date":"2026-09-16","current":-10.869219,"percent":0.349398,"low":-27.074722,"twenty":-17.23221,"median":-11.217823,"eighty":-9.909647,"high":-8.802064,"avg":-13.946372,"sd":5.354921,"marketCap":4947391099},"quantilePoints":[{"date":"2026-01-16","current":-9.013032,"twenty":-8.970838,"median":-8.907548,"eighty":-8.844258,"marketCap":1515072711},{"date":"2026-01-23","current":-9.944809,"twenty":-9.944809,"median":-9.423248,"eighty":-8.819645,"marketCap":1671702464},{"date":"2026-01-30","current":-10.103035,"twenty":-10.103035,"median":-9.868626,"eighty":-9.013032,"marketCap":1698299969},{"date":"2026-02-06","current":-9.522872,"twenty":-10.196799,"median":-9.918438,"eighty":-9.522872,"marketCap":1600775783},{"date":"2026-02-13","current":-9.511152,"twenty":-10.179218,"median":-9.944809,"eighty":-9.522872,"marketCap":1598805598},{"date":"2026-02-20","current":-10.120616,"twenty":-10.18039,"median":-9.944809,"eighty":-9.520528,"marketCap":1701255248},{"date":"2026-02-27","current":-9.267085,"twenty":-10.187422,"median":-9.96239,"eighty":-9.520528,"marketCap":1703225433},{"date":"2026-03-06","current":-9.519961,"twenty":-10.18039,"median":-9.903787,"eighty":-9.502065,"marketCap":1749702163},{"date":"2026-03-13","current":-9.753213,"twenty":-10.18039,"median":-9.918437,"eighty":-9.518199,"marketCap":1792572359},{"date":"2026-03-20","current":-10.122078,"twenty":-10.169841,"median":-9.903787,"eighty":-9.52229,"marketCap":1860367087},{"date":"2026-03-27","current":-10.273963,"twenty":-10.169841,"median":-9.918437,"eighty":-9.559599,"marketCap":1888282563},{"date":"2026-04-02","current":-11.174427,"twenty":-10.181562,"median":-9.918437,"eighty":-9.550417,"marketCap":2053781457},{"date":"2026-04-10","current":-11.619234,"twenty":-10.247114,"median":-9.944809,"eighty":-9.57529,"marketCap":2135533923},{"date":"2026-04-17","current":-12.18338,"twenty":-10.396104,"median":-9.980506,"eighty":-9.589394,"marketCap":2239219977},{"date":"2026-04-24","current":-12.617338,"twenty":-11.167918,"median":-10.038572,"eighty":-9.618687,"marketCap":2318978480},{"date":"2026-05-01","current":-11.86876,"twenty":-11.389236,"median":-10.10442,"eighty":-9.643639,"marketCap":2181395062},{"date":"2026-05-08","current":-13.767387,"twenty":-11.71579,"median":-10.122078,"eighty":-9.665202,"marketCap":2530349365},{"date":"2026-05-15","current":-9.802755,"twenty":-11.643102,"median":-10.113211,"eighty":-9.689477,"marketCap":2328575817},{"date":"2026-05-22","current":-10.399644,"twenty":-11.570414,"median":-10.105791,"eighty":-9.636028,"marketCap":2470362634},{"date":"2026-05-29","current":-10.780735,"twenty":-11.483622,"median":-10.120616,"eighty":-9.642537,"marketCap":2560888064},{"date":"2026-06-05","current":-11.290386,"twenty":-11.393576,"median":-10.145827,"eighty":-9.660184,"marketCap":2681952193},{"date":"2026-06-12","current":-11.069996,"twenty":-11.344489,"median":-10.179218,"eighty":-9.68473,"marketCap":2629600138},{"date":"2026-06-18","current":-11.216923,"twenty":-11.349156,"median":-10.196799,"eighty":-9.702279,"marketCap":2664501508},{"date":"2026-06-26","current":-20.565124,"twenty":-11.510745,"median":-10.247973,"eighty":-9.723056,"marketCap":4885101210},{"date":"2026-07-02","current":-24.252692,"twenty":-11.77112,"median":-10.299843,"eighty":-9.753213,"marketCap":5761057223},{"date":"2026-07-10","current":-27.074722,"twenty":-12.069466,"median":-10.333633,"eighty":-9.796609,"marketCap":6431410656},{"date":"2026-07-17","current":-24.643864,"twenty":-12.519698,"median":-10.492938,"eighty":-9.802755,"marketCap":5853977501},{"date":"2026-07-24","current":-23.990048,"twenty":-12.931958,"median":-10.537388,"eighty":-9.812883,"marketCap":5698667894},{"date":"2026-07-31","current":-24.861803,"twenty":-14.440728,"median":-10.67054,"eighty":-9.817222,"marketCap":5905747370},{"date":"2026-08-07","current":-17.312135,"twenty":-19.588062,"median":-10.789918,"eighty":-9.824231,"marketCap":6124773739},{"date":"2026-08-14","current":-16.673146,"twenty":-17.887875,"median":-10.831241,"eighty":-9.831914,"marketCap":5898709105},{"date":"2026-08-21","current":-17.242844,"twenty":-17.526933,"median":-11.058518,"eighty":-9.861594,"marketCap":6100259530},{"date":"2026-08-28","current":-16.642763,"twenty":-17.426666,"median":-11.092954,"eighty":-9.887379,"marketCap":5887959749},{"date":"2026-09-04","current":-14.432336,"twenty":-17.33018,"median":-11.139168,"eighty":-9.901443,"marketCap":5105944100},{"date":"2026-09-11","current":-14.329791,"twenty":-17.27056,"median":-11.195675,"eighty":-9.903787,"marketCap":5069665023},{"date":"2026-09-16","current":-13.984174,"twenty":-17.23221,"median":-11.217823,"eighty":-9.909647,"marketCap":4947391099}],"updateTime":1789641017726},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DFTX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667765049","title":"Definium Therapeutics: DT120 Odt 100 Mcg Generally Well Tolerated with Consistent Safety Profile; no New Safety Signals","url":"https://stock-news.laohu8.com/highlight/detail?id=2667765049","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667765049?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:00","pubTimestamp":1789383600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nP8N40P08T:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667650490","title":"Definium Therapeutics: DT120 Pre-Nda Meeting Scheduled for Q4; Nda Filing Expected H1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2667650490","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667650490?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:00","pubTimestamp":1789383600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nP8N40P08T:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667650415","title":"Definium Therapeutics: Phase 3 Panorama Study of DT120 Odt Met Primary & Key Secondary Endpoints in Generalized Anxiety Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2667650415","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667650415?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:00","pubTimestamp":1789383600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nP8N40P08T:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667507966","title":"Definium's LSD-Based Drug Lowers Anxiety in Second Successful Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2667507966","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667507966?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:00","pubTimestamp":1789383600,"startTime":"0","endTime":"0","summary":"Definium's LSD-based drug lowers anxiety in second successful late-stage studySept 14-Definium TherapeuticsDFTX.Osaid on Monday its LSD-based treatment reduced symptoms of generalized anxiety disorder","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL6N4560MS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667418650","title":"Definium Therapeutics: DT120 Odt 100 Mcg Showed Placebo-Adjusted Hamilton Anxiety Rating Scale Reduction of 5.1 Points at Week 12","url":"https://stock-news.laohu8.com/highlight/detail?id=2667418650","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667418650?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:00","pubTimestamp":1789383600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nP8N40P08T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667148650","title":"NASDAQ Trade Halt Halt News Pending at 06:55 Am","url":"https://stock-news.laohu8.com/highlight/detail?id=2667148650","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667148650?lang=en_us&edition=fundamental","pubTime":"2026-09-14 18:55","pubTimestamp":1789383300,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTHALT NEWS PENDING AT 06:55 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nAQN2MJ4TH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667657172","title":"U.S. Research Roundup-ACV Auctions, Crown Castle, Lennox International","url":"https://stock-news.laohu8.com/highlight/detail?id=2667657172","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667657172?lang=en_us&edition=fundamental","pubTime":"2026-09-14 18:22","pubTimestamp":1789381349,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-ACV Auctions, Crown Castle, Lennox InternationalSept 14 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, includ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL4N4560NX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DK","MAAY","BE","MARA","MARO","ACVA","KR","CPK","LII","FLNC","CALY","OWNB","EXP","DTCR","ERII","CAPR","ADBG","CCI","DFTX","KRSA","LRMR","MPC","ADBE","GM","CPT","DBI","EIX","SMOG","JKHY","EBAY","XTN","ADUS","LYNX","DINO","FIG","BEX","CRWV","FCNCA","FRSH","DVN","DRI","EGP","AZO","GSIT","CEVA","ECHO","ALGT","GXPE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667652775","title":"Definium Therapeutics Issues Inducement Stock Options for 56,650 Shares to New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2667652775","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667652775?lang=en_us&edition=fundamental","pubTime":"2026-09-14 18:00","pubTimestamp":1789380036,"startTime":"0","endTime":"0","summary":"Definium Therapeutics issues inducement stock options for 56,650 shares to new hiresDefinium Therapeutics issued inducement stock options covering 56,650 common shares to three newly hired non-executi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDL36dVPz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667335576","title":"Definium Therapeutics to Present Phase 3 Panorama Topline Data for DT120 in Generalized Anxiety Disorder Sept. 14","url":"https://stock-news.laohu8.com/highlight/detail?id=2667335576","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667335576?lang=en_us&edition=fundamental","pubTime":"2026-09-14 05:00","pubTimestamp":1789333219,"startTime":"0","endTime":"0","summary":"Definium Therapeutics to present Phase 3 Panorama topline data for DT120 in generalized anxiety disorder Sept. 14Definium Therapeutics scheduled a Sept. 14, 2026 webcast to discuss topline results fro","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260913:nNDL5r74pJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667633552","title":"Definium Therapeutics to Discuss Topline Results from Phase 3 Panorama Study in Generalized Anxiety Disorder on September 14, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2667633552","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667633552?lang=en_us&edition=fundamental","pubTime":"2026-09-14 05:00","pubTimestamp":1789333201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260913:nTUA4KL4QW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666257316","title":"Definium Therapeutics' Upcoming Phase 3 Data on DT120 to De-Risk Program, Back FDA Approval, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2666257316","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666257316?lang=en_us&edition=fundamental","pubTime":"2026-09-11 23:33","pubTimestamp":1789140826,"startTime":"0","endTime":"0","summary":"Definium Therapeutics'  upcoming phase 3 data on DT120 in generalized anxiety disorder or GAD is likely to further de-risk the program and back potential approval, RBC Capital Markets said in a Friday note.The first phase 3 trial in GAD met its primary endpoint and a positive data readout from the second phase 3 trial should ease residual regulatory uncertainty on the therapy's approvability, the brokerage said. Data from the second phase 3 trial is due for release \"any day now,\" RBC noted.Trial results are likely to support approval from the US Food and Drug Administration given DT120's robust efficacy data, well-powered studies, and the FDA's flexibility for neuropsychiatric drugs, according to the investment firm.RBC has an outperform rating on Definium Therapeutics, with a $66 price target.Price: 38.53, Change: +0.80, Percent Change: +2.12","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","BK4585","DFTX","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666520965","title":"Definium Therapeutics Price Target Maintained with a $66.00/Share by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2666520965","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666520965?lang=en_us&edition=fundamental","pubTime":"2026-09-11 21:58","pubTimestamp":1789135080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DFTX/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666560248","title":"Definium Therapeutics announce six poster presentations at Psych Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2666560248","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666560248?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:05","pubTimestamp":1789038322,"startTime":"0","endTime":"0","summary":"Definium Therapeutics (DFTX) announced six poster presentations at the Psych Congress taking place September 15 through 19 in New Orleans, LA. “Thi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-announce-six-poster-presentations-at-psych-congress-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-announce-six-poster-presentations-at-psych-congress-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666670095","title":"Definium Therapeutics to Present Phase 3 Topline Data for DT120 in MDD, GAD at Psych Congress 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2666670095","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666670095?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:00","pubTimestamp":1789038047,"startTime":"0","endTime":"0","summary":"Definium Therapeutics to present Phase 3 topline data for DT120 in MDD, GAD at Psych Congress 2026Definium Therapeutics scheduled topline Phase 3 results for DT120 in major depressive disorder, genera","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDLbR4qcr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666372197","title":"Analyst Reiterates Buy on Definium Therapeutics, Maintains $75 Price Target Following De-Risking of DT120 ODT in MDD and GAD","url":"https://stock-news.laohu8.com/highlight/detail?id=2666372197","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666372197?lang=en_us&edition=fundamental","pubTime":"2026-09-09 03:25","pubTimestamp":1788895521,"startTime":"0","endTime":"0","summary":"Analyst Francois Brisebois of LifeSci Capital reiterated a Buy rating on Definium Therapeutics, retaining the price target of $75.00. Francois Bris...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-definium-therapeutics-maintains-75-price-target-following-de-risking-of-dt120-odt-in-mdd-and-gad-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-definium-therapeutics-maintains-75-price-target-following-de-risking-of-dt120-odt-in-mdd-and-gad-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ODT","ABVC","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374542","title":"U.S. Stocks on the MOVE-Best Buy, Peloton, Apple","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374542","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666374542?lang=en_us&edition=fundamental","pubTime":"2026-09-09 01:36","pubTimestamp":1788889011,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Best Buy, Peloton, AppleSeptember 8 (Reuters)-The major U.S. stock indexes edged lower on Tuesday as fresh hostilities in the Middle East pushed oil prices higher, while m","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL6N4500HU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IONX","UNFI","MTB","SRPT","DYN","CHRW","ILMN","INTC","ALV","HWM","IONQ","RGTI","NTLA","COHR","SEI","SMHX","QNT","AAPL","QCMD","QCOM","COHX","BE","EFSI","QBTS","COHH","BSX","IONS","AMD","PHVS","TTXU","P","AMGN","SINTCmain","ABM","INFQ","SAAPLmain","ROIV","SHAK","LITE","RPRX","CQTM","DAMD","NATO","ROM","BHVN","MACW.SI","DFTX","SPTE","AAPU","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665788375","title":"Definium Rises on FDA's 'breakthrough' Tag for Depression Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2665788375","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665788375?lang=en_us&edition=fundamental","pubTime":"2026-09-08 21:58","pubTimestamp":1788875939,"startTime":"0","endTime":"0","summary":"BUZZ-Definium rises on FDA's 'breakthrough' tag for depression drug** Shares of Definium TherapeuticsDFTX.Orise 2.2% to $38.92** Co says its LSD-based experimental pill DT120receivesFDA breakthrough t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4N45013M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665937815","title":"Definium Therapeutics Gains FDA Breakthrough for Depression Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2665937815","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665937815?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:35","pubTimestamp":1788870934,"startTime":"0","endTime":"0","summary":"Definium Therapeutics ( ($DFTX) ) just unveiled an announcement. On September 8, 2026, Definium Therapeutics announced that the U.S. Food and Drug ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-gains-fda-breakthrough-for-depression-drug?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-gains-fda-breakthrough-for-depression-drug?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4007","LABU","DFTX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665387327","title":"Definium Therapeutics receives Breakthrough Therapy designation for DT120 ODT","url":"https://stock-news.laohu8.com/highlight/detail?id=2665387327","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665387327?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:11","pubTimestamp":1788865879,"startTime":"0","endTime":"0","summary":"Definium Therapeutics (DFTX) announced that the U.S. Food and Drug Administration, FDA, has granted Breakthrough Therapy designation for DT120 Oral...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-receives-breakthrough-therapy-designation-for-dt120-odt-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-receives-breakthrough-therapy-designation-for-dt120-odt-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LABU","BK4007","DFTX","BK4588","ODT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322932","title":"Definium Therapeutics’ DT120 LSD Tablet Wins FDA Breakthrough Tag in Major Depressive Disorder After Phase 3 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322932","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322932?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:01","pubTimestamp":1788865271,"startTime":"0","endTime":"0","summary":"Definium Therapeutics’ DT120 LSD tablet wins FDA breakthrough tag in major depressive disorder after Phase 3 studyDefinium Therapeutics received FDA Breakthrough Therapy designation for DT120 orally d","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLbMTXrl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}